Total US stock market ETFs compared: returns and risk
Funds that hold the whole US market or its large and mid companies, from a few hundred to several thousand stocks.
Data updated October 2026
| Fund | 1Y | 3Y a yr | 5Y a yr | 10Y a yr | Volatility | Max drawdown | Since |
|---|---|---|---|---|---|---|---|
 VTIVanguard Total Stock Market ETF | +16.0% | +22.7% | +11.5% | — | 17.2% | −25.4% | 2020 |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | +15.7% | +22.6% | +11.5% | +14.8% | 19.5% | −55.9% | 2006 |
| SCHBSchwab U.S. Broad Market ETF | +16.0% | +22.4% | +10.9% | +13.7% | 17.4% | −35.3% | 2009 |
| IWBiShares Russell 1000 ETF | +15.9% | +22.7% | +11.9% | +15.1% | 19.4% | −55.4% | 2006 |
| SCHXSchwab U.S. Large-Cap ETF | +15.9% | +22.6% | +11.4% | +14.1% | 17.2% | −34.3% | 2009 |
| VXFVanguard Extended Market ETF | +25.9% | +24.9% | +7.6% | — | 22.2% | −36.4% | 2020 |
Total returns with dividends reinvested, in each fund’s trading currency, to the last close; periods longer than a year are annualised. Volatility and maximum drawdown cover each fund’s whole history since the year shown, so they are comparable only between funds with similar start dates.
Head-to-head comparisons
Other ETF categories
- S&P 500 ETFs
- Nasdaq-100 ETFs
- Dow Jones and equal-weight ETFs
- US small and mid cap ETFs
- US growth ETFs
- US value ETFs
- Small cap value and growth ETFs
- Dividend ETFs
- Covered call and equity income ETFs
- Factor ETFs (min vol, quality, momentum, value)
- World and all-world ETFs
- International developed markets ETFs
- Europe ETFs
- Emerging markets and Asia ETFs
- Technology and semiconductor ETFs
- US sector ETFs
- Real estate (REIT) ETFs
- Thematic ETFs
- US Treasury bond ETFs
- Inflation-linked bond ETFs
- Aggregate bond ETFs
- Corporate, high yield and municipal bond ETFs
- Cash and T-bill ETFs
- Gold and precious metals ETFs
- Oil, gas and commodity ETFs
- Bitcoin and crypto ETFs
- Leveraged and inverse ETFs
- Allocation and multi-asset ETFs
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.